Multiple Assemblies exist for SMTL entry 3e8c
Crystal structures of the kinase domain of PKA in complex with ATP-competitive inhibitors; X-RAY DIFFRACTION 2.20 Å

	SMTL ID 3e8c.1 Ligands 4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-6-{[(2R)-2-amino-3-phenylpropyl]oxy}-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol Polypeptides cAMP-dependent protein kinase catalytic subunit alpha; cAMP-dependent protein kinase inhibitor peptide Oligo-state hetero-1-1-mer
	SMTL ID 3e8c.2 Ligands 4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-6-{[(2R)-2-amino-3-phenylpropyl]oxy}-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol Polypeptides cAMP-dependent protein kinase catalytic subunit alpha; cAMP-dependent protein kinase inhibitor peptide Oligo-state hetero-1-1-mer
	SMTL ID 3e8c.3 Ligands 4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-6-{[(2R)-2-amino-3-phenylpropyl]oxy}-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol Polypeptides cAMP-dependent protein kinase catalytic subunit alpha; cAMP-dependent protein kinase inhibitor peptide Oligo-state hetero-1-1-mer
	SMTL ID 3e8c.4 Ligands 4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-6-{[(2R)-2-amino-3-phenylpropyl]oxy}-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol Polypeptides cAMP-dependent protein kinase catalytic subunit alpha; cAMP-dependent protein kinase inhibitor peptide Oligo-state hetero-1-1-mer
	SMTL ID 3e8c.5 Ligands 4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-6-{[(2R)-2-amino-3-phenylpropyl]oxy}-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol Polypeptides cAMP-dependent protein kinase catalytic subunit alpha; cAMP-dependent protein kinase inhibitor peptide Oligo-state hetero-1-1-mer
	SMTL ID 3e8c.6 Ligands 4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-6-{[(2R)-2-amino-3-phenylpropyl]oxy}-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol Polypeptides cAMP-dependent protein kinase catalytic subunit alpha; cAMP-dependent protein kinase inhibitor peptide Oligo-state hetero-1-1-mer